TTBIO CORP.(TW:6493)
NT$28.80-0.25 (-0.86%)
TW:6493
TTBIO CORP. financials statements
NT$28.80
At close:-0.25 (-0.86%)
TTBIO CORP. (6493) Ratios
TTBIO CORP. Ratios
TW:6493's free cash flow for Q2 2026 was NT$-42.76M. For the 2026 fiscal year, TW:6493's free cash flow was decreased by NT$-6.84M and operating cash flow was NT$-35.91M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.37 | 1.83 | 2.04 | 2.13 | 2.17 |
| Quick Ratio | 0.76 | 0.81 | 0.81 | 1.08 | 1.01 |
| Cash Ratio | 0.31 | 0.41 | 0.38 | 0.71 | 0.56 |
| Solvency Ratio | 0.06 | 0.13 | 0.23 | 0.39 | 0.29 |
| Operating Cash Flow Ratio | -0.24 | 0.12 | 0.03 | 0.32 | 0.38 |
| Short-Term Operating Cash Flow Coverage | -0.44 | 0.24 | 0.04 | 0.63 | 1.48 |
| Net Current Asset Value | NT$ 145.88M | NT$ 58.67M | NT$ 104.11M | NT$ 134.49M | NT$ 100.54M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.28 | 0.35 | 0.28 | 0.24 | 0.16 |
| Debt-to-Equity Ratio | 0.49 | 0.72 | 0.48 | 0.39 | 0.26 |
| Debt-to-Capital Ratio | 0.33 | 0.42 | 0.33 | 0.28 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.11 | 0.14 | 0.10 | 0.09 |
| Financial Leverage Ratio | 1.74 | 2.06 | 1.71 | 1.63 | 1.57 |
| Debt Service Coverage Ratio | 0.15 | 0.43 | 0.51 | 0.99 | 1.52 |
| Interest Coverage Ratio | -3.89 | -0.46 | -0.37 | 24.31 | 10.40 |
| Debt to Market Cap | 0.16 | 0.30 | 0.28 | 0.18 | 0.12 |
| Interest Debt Per Share | 6.69 | 9.04 | 6.16 | 5.29 | 3.21 |
| Net Debt to EBITDA | 8.20 | 2.75 | 1.64 | 0.14 | 0.11 |
| Profitability Margins | |||||
| Gross Profit Margin | 12.47% | 23.32% | 24.65% | 29.25% | 29.61% |
| EBIT Margin | -5.32% | 2.67% | 3.27% | 11.91% | 5.01% |
| EBITDA Margin | 3.71% | 15.12% | 16.38% | 21.32% | 17.21% |
| Operating Profit Margin | -5.32% | -0.73% | -0.27% | 9.16% | 4.01% |
| Pretax Profit Margin | -5.30% | 1.09% | 2.54% | 11.53% | 4.62% |
| Net Profit Margin | -5.34% | 0.83% | 2.10% | 9.50% | 3.77% |
| Continuous Operations Profit Margin | -5.34% | 0.83% | 2.10% | 9.50% | 3.77% |
| Net Income Per EBT | 100.81% | 76.22% | 82.54% | 82.38% | 81.68% |
| EBT Per EBIT | 99.52% | -148.51% | -938.40% | 125.93% | 115.18% |
| Return on Assets (ROA) | -3.42% | 0.43% | 1.30% | 7.56% | 2.48% |
| Return on Equity (ROE) | -5.96% | 0.88% | 2.23% | 12.32% | 3.90% |
| Return on Capital Employed (ROCE) | -4.72% | -0.56% | -0.24% | 10.43% | 3.60% |
| Return on Invested Capital (ROIC) | -3.92% | -0.34% | -0.16% | 6.94% | 2.64% |
| Return on Tangible Assets | -3.61% | 0.46% | 1.46% | 8.62% | 2.94% |
| Earnings Yield | -2.91% | 0.54% | 1.28% | 6.12% | 2.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.28 | 4.80 | 5.77 | 9.29 | 6.25 |
| Payables Turnover | 9.64 | 7.61 | 10.52 | 11.63 | 5.18 |
| Inventory Turnover | 1.25 | 1.16 | 1.26 | 1.78 | 1.50 |
| Fixed Asset Turnover | 2.48 | 1.78 | 2.70 | 4.69 | 3.40 |
| Asset Turnover | 0.64 | 0.51 | 0.62 | 0.80 | 0.66 |
| Working Capital Turnover Ratio | 1.96 | 1.89 | 1.87 | 2.58 | 2.33 |
| Cash Conversion Cycle | 312.58 | 344.17 | 319.27 | 213.09 | 231.41 |
| Days of Sales Outstanding | 58.13 | 76.09 | 63.21 | 39.30 | 58.37 |
| Days of Inventory Outstanding | 292.30 | 316.02 | 290.76 | 205.19 | 243.56 |
| Days of Payables Outstanding | 37.84 | 47.93 | 34.70 | 31.40 | 70.52 |
| Operating Cycle | 350.43 | 392.10 | 353.97 | 244.49 | 301.93 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.52 | 1.05 | 0.17 | 2.08 | 1.96 |
| Free Cash Flow Per Share | -1.85 | 0.69 | -1.65 | 0.37 | 1.27 |
| Dividend Paid and CapEx Coverage Ratio | -2.73 | 1.58 | 0.05 | 0.94 | 2.83 |
| Capital Expenditure Coverage Ratio | -4.56 | 2.87 | 0.09 | 1.21 | 2.83 |
| Operating Cash Flow Coverage Ratio | -0.23 | 0.12 | 0.03 | 0.40 | 0.62 |
| Operating Cash Flow to Sales Ratio | -0.10 | 0.08 | 0.01 | 0.12 | 0.15 |
| Free Cash Flow Yield | -6.84% | 3.45% | -7.53% | 1.36% | 5.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -34.30 | 180.91 | 78.04 | 17.01 | 44.81 |
| Price-to-Sales (P/S) Ratio | 1.83 | 1.53 | 1.64 | 1.55 | 1.69 |
| Price-to-Book (P/B) Ratio | 2.05 | 1.62 | 1.74 | 2.01 | 1.75 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.63 | 28.99 | -13.28 | 73.80 | 16.98 |
| Price-to-Operating Cash Flow Ratio | -17.84 | 18.88 | 130.42 | 12.98 | 10.98 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -2.98 | -0.95 | 0.07 | -0.60 |
| Enterprise Value Multiple | 57.59 | 12.89 | 11.63 | 7.43 | 9.95 |
| Enterprise Value | 852.84M | 608.43M | 606.30M | 663.26M | 523.12M |
| EV to EBITDA | 57.59 | 12.89 | 11.63 | 7.43 | 9.95 |
| EV to Sales | 2.14 | 1.95 | 1.91 | 1.58 | 1.71 |
| EV to Free Cash Flow | -17.05 | 36.86 | -15.45 | 75.24 | 17.17 |
| EV to Operating Cash Flow | -20.80 | 24.00 | 151.76 | 13.24 | 11.10 |
| Tangible Book Value Per Share | 12.03 | 10.46 | 10.31 | 10.73 | 9.26 |
| Shareholders’ Equity Per Share | 13.24 | 12.27 | 12.57 | 13.43 | 12.29 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.24 | 0.17 | 0.18 | 0.18 |
| Revenue Per Share | 14.78 | 12.98 | 13.34 | 17.42 | 12.70 |
| Net Income Per Share | -0.79 | 0.11 | 0.28 | 1.65 | 0.48 |
| Tax Burden | 1.01 | 0.76 | 0.83 | 0.82 | 0.82 |
| Interest Burden | 1.00 | 0.41 | 0.78 | 0.97 | 0.92 |
| Research & Development to Revenue | 0.06 | 0.08 | 0.08 | 0.07 | 0.09 |
| SG&A to Revenue | 0.12 | 0.16 | 0.17 | 0.13 | 0.17 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.93 | 7.46 | 0.60 | 1.26 | 4.09 |
Currency in TWD
